US EditionSouth Africa's Aspen to Sell Major APAC Operations for $1.6 Billion
Aspen Pharmacare will use A$2.37 billion from the sale of Asia Pacific assets to reduce R31.2 billion debt and simplify its lender base, the company said.
9 Articles
9 Articles
South Africa's Aspen to sell major APAC operations for $1.6 billion
Aspen Pharmacare will sell its major Asia Pacific assets, excluding China, to Australian private equity firm BGH Capital for A$2.37 billion ($1.59 billion), the South African group said on Monday, as it looks to cut debt and boost capital.
Times Live
bizcommunity.comAspen to sell major Asia Pacific assets to Australian firm for R26bn
Aspen Pharmacare, South Africa’s biggest pharmaceutical producer, will sell its major Asia Pacific assets, excluding China, to Australian private equity firm BGH Capital for A$2.37bn (R26.45bn), the group said on Monday.
Aspen Pharmacare Holdings, Africa’s leading drug manufacturer, announced this Monday that it will sell its assets in the Asia-Pacific region except those located in China to the Australian BGH Capital fund for 26,477 million South African rands (1,348 million euros). According to the sales document, all of the assets will be transferred [...] The entry Aspen Pharmacare, Africa’s largest pharmaceutical company, will sell its Asian assets to BHG f…
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
